599 results on '"diabetology"'
Search Results
302. Priority areas in management of diabetes mellitus type 1 & 2 (following 47th EASD Annual Meeting)
- Author
-
Ivona Renata Yarek-Martynova and Lyubov' Leonidovna Bolotskaya
- Subjects
medicine.medical_specialty ,RC620-627 ,Endocrinology, Diabetes and Metabolism ,exenatide ,Treatment goals ,Lixisenatide ,chemistry.chemical_compound ,Endocrinology ,Internal medicine ,Diabetes mellitus ,Internal Medicine ,medicine ,Nutritional diseases. Deficiency diseases ,Glycemic ,insulin glulisin ,business.industry ,Diabetology ,medicine.disease ,Priority areas ,chemistry ,Family medicine ,insulin therapy ,diabetes mellitus ,easd ,business ,lixisenatide ,insulin glargin - Abstract
Individualization of treatment goals is a modern trend in diabetology. During 47th Annual Meeting of European Association for the Study of Diabetesthis very problem was addressed repeatedly. The Sanofi Satellite Symposium under the name A step towards individualizing care to achieve earlyand sustained glycemic control presented lectures of worlds leading experts, giving priority to the problem of early diagnosis and early interventionfor individuals with T2DM, as well as potential benefits of early insulinisation, significance of adequate self-monitoring and pharmacoeconomicaspects of diabetes care.
- Published
- 2011
303. The point-of-care testing in diabetology
- Author
-
Ottavio Giampietro and Elena Matteucci
- Subjects
medicine.medical_specialty ,HbA1c ,Urinary albumin ,Point-of-care testing ,Medicine (miscellaneous) ,Early detection ,Diabetes mellitus ,Internal medicine ,Point-of-care systems ,Blood glucose ,Ketones ,Lipids ,medicine ,Intensive care medicine ,lcsh:R5-920 ,business.industry ,Haemoglobin A1c ,Diabetology ,medicine.disease ,Endocrinology ,Business, Management and Accounting (miscellaneous) ,Clinical Medicine ,lcsh:Medicine (General) ,business - Abstract
In diabetic patients glucose, haemoglobin A1c, ketones, lipids, and urinary albumin monitoring allows prevention, early detection, and treatment of diabetes-related acute and chronic complications. The point-of-care testing (PoCT) technology offers convenient aspects, as long as pre-analytical, analytical, and post-analytical errors are minimised. The overview summarises the current state-of-the-art of PoCT in diabetes care.
- Published
- 2011
304. Hypoglycemia in the hospital
- Author
-
Mansur E. Shomali
- Subjects
medicine.medical_specialty ,Pediatrics ,insulin ,lcsh:Internal medicine ,Hospitalized patients ,medicine.medical_treatment ,Alternative medicine ,hypoglycemia ,hospital ,diabetes ,Hypoglycemia ,endocrinology ,diabetology ,Diabetes mellitus ,Internal Medicine ,medicine ,Adverse effect ,Intensive care medicine ,lcsh:RC31-1245 ,Scope (project management) ,business.industry ,Insulin ,hospitalized patients ,nutritional and metabolic diseases ,medicine.disease ,business ,Perspectives - Abstract
Hypoglycemia is a common adverse event affecting hospitalized patients with diabetes. This paper reviews the data regarding optimization of glucose in hospitalized patients, discusses the scope and significance of hypoglycemia in the hospital, and makes recommendations on how to reduce the risk of this serious adverse event. Keywords: hypoglycemia; hospital; diabetes; insulin(Published: 18 July 2011)Citation: Journal of Community Hospital Internal Medicine Perspectives 2011, 1: 7217 - DOI: 10.3402/jchimp.v1i2.7217
- Published
- 2011
305. Extraskeletal effects of vitamin D
- Author
-
Maurizio Rossini
- Subjects
medicine.medical_specialty ,Type 1 diabetes ,business.industry ,General Medicine ,Disease ,Type 2 diabetes ,Extraskeletal effects ,Vitamin D ,Supplementation ,medicine.disease ,Gastroenterology ,Endocrinology ,Internal medicine ,Rheumatology ,Geriatrics ,Cardiology ,General medicine ,Diabetology ,Oncology ,Infettivology ,Pneumology ,Dermatology ,Neurology ,Physical medicine and rehabilitation ,Orthopaedics ,Sarcopenia ,Diabetes mellitus ,Rheumatoid arthritis ,Vitamin D and neurology ,medicine ,Metabolic syndrome ,business - Abstract
In the last years we observed an increasing number of publications about the vitamin D, due to its recognised therapeutic actions and to the widespread hypovitaminosis D. In addition to the well known skeletal benefits, vitamin D can have multiple effects on other tissues.Muscular apparatus: hypovitaminosis D is associated with myopathy, sarcopenia, muscular strength reduction and increased risk of falls. The vitamin D supplementation increases the muscle functionality indexes. Cardiovascular system: low levels of vitamin D are related to increased levels of cardiovascular risk factors, heart failure, stroke, and cardiovascular mortality, while a good vitamin D status is associated with a decreased incidence of cardiovascular diseases. Diabetes and metabolic syndrome: a good vitamin D status is related to a decreased incidence of type 2 diabetes and metabolic syndrome; a vitamin D supplementation in the early childhood reduces (nearly 30%) the risk of having type 1 diabetes. Cancer: vitamin D deficit is associated with breast, colorectal cancer and melanoma relapses. Low and high levels of 25-hydroxy-vitamin D (25(OH)D) are related to a higher neoplastic mortality. Infectious diseases: hypovitaminosis D is associated with higher incidence of upper respiratory tract infections and worse interferon response in chronic hepatitis C. Vitamin D supplementation decreases the risk of having type A influence. Rheumatic diseases: in rheumatoid arthritis low serum levels of vitamin D metabolites are related to a higher disease activity, while a good vitamin D status is associated with a higher probability of remission or response to therapy and a lower degree of disability. Neurologic diseases: associations between vitamin D deficit and risk of multiple sclerosis, depression, cognitive deficits, and Parkinson’s disease have been reported.There is evidence of the extraskeletal effects of vitamin D, but most derive from observational studies: clinical trials are required the better to determine the therapeutic role of vitamin D.
- Published
- 2011
306. Diabetesversorgung und Schwerpunktpraxis - Aktueller Stand und Perspektiven
- Author
-
Erik Bodendieck, Hans-Joachim Verlohren, Ulrike Rothe, and Jan Schulze
- Subjects
Gynecology ,Pediatrics ,medicine.medical_specialty ,business.industry ,Endocrinology, Diabetes and Metabolism ,Internal Medicine ,medicine ,Diabetology ,business - Abstract
Die Betreuung von Diabetespatienten, als Paradebeispiel fur die Betreuung chronisch Erkrankter, erfordert kooperative Strukturen im Versorgungssystem. Die Diabetologische Schwerpunktpraxis (DSP) ist ein wesentlicher Bestandteil dieses Systems. In einer Ubersicht wird die Bedeutung der DSP, ihr gegenwartiges und zukunftig zu erwartendes Arbeitsspektrum angesprochen. Es konnte in der Vergangenheit belegt werden, dass integrierte Versorgungssysteme nur durch adaquate Kooperation von Hausarzten und Diabetologen in DSP hinsichtlich ihrer Effektivitat zu verantwortbaren Ergebnissen fuhren. Der Erfolg integrierter Versorgungsprogramme, die konkrete Therapiezielfestlegungen sowie konkrete Uberweisungskriterien beinhalten, wird anhand des Outcomes von Evaluationsstudien belegt. Ein kunftiger Ubergang vom Disease-Management einzelner chronischer Erkrankungen hin zu einem effizienteren diagnoseubergreifenden „Chronic-Care-Management“ lasst eine weitere Intensivierung der Kooperation von Generalisten und Spezialisten erwarten. The management of diabetes patients, as a classic example for management of the chronically ill, requires cooperative structure in the health-care system. The Diabetology Specialist Practice (DSP) is an essential part of this system. The significance of the DSP, its current and expected future fields of activity are reviewed. In the past it has been demonstrated that integrated health-care systems can only lead to acceptable results with regard to efficacy through an adequate cooperation between general practitioners and diabetologist in DSPs. The success of integrated management programs that include the setting of concrete therapeutic targets as well as concrete referral criteria has been confirmed by the outcomes of evaluation studies. A future transition from disease management of individual chronic diseases to a more efficient diagnosis-independent chronic care management should lead to a further intensification of the cooperation between general practitioners and specialists.
- Published
- 2011
307. Education of diabetic patients: synthesis of evidence-based medicine and psychological approach
- Author
-
Alexander Yur'evich Mayorov, Elena Viktorovna Surkova, Oleg Gennad'evich Motovilin, Olga Georgievna Mel'nikova, and Yulia Andreevna Shishkova
- Subjects
education ,medicine.medical_specialty ,RC620-627 ,Modality (human–computer interaction) ,business.industry ,Endocrinology, Diabetes and Metabolism ,Alternative medicine ,psychological characteristic ,Diabetology ,Context (language use) ,Diabetes education ,medicine.disease ,Endocrinology ,Family medicine ,Diabetes mellitus ,diabetes mellitus ,Internal Medicine ,medicine ,Nutritional diseases. Deficiency diseases ,business ,Psychosocial - Abstract
Education of diabetic patients is not only an applied but also a research branch of diabetology. The efficacy of this therapeutic modality must be assessedin accordance with the principles of evidence-based medicine. At the same time, it extends beyond the framework of standard medical actionsand implies the necessity of taking into account the psychosocial context. The main stages of the development of diabetes education at the EndocrinologicalResearch Centre are reviewed including evaluation of the efficacy of structured programs, cooperation with international institutions,and development of new methods. Psychological characteristics of diabetic patients are discussed with reference to taking them into account for thepurpose of education.
- Published
- 2011
308. Diabetes mellitus and chronic kidney disease: achievements, unresolved problems, and prospects for therapy
- Author
-
Sergey Andreevich Martynov, Olga Yur'evna Sukhareva, Minara Shamkhalovna Shamkhalova, Marina Vladimirovna Shestakova, Natalya Vladislavovna Zaytseva, Olga K. Vikulova, Malkhaz Viktorovich Kvaratskheliya, Ivona Yanovna Yarek-Martynova, Evgeny Vladimirovich Tarasov, Natalya Petrovna Trubitsyna, and Inna Igorevna Klefortova
- Subjects
Nephrology ,medicine.medical_specialty ,RC620-627 ,business.industry ,Endocrinology, Diabetes and Metabolism ,Public health ,diabetic nephropathy ,Diabetology ,Chronic renal disease ,medicine.disease ,renoprotection ,Diabetic nephropathy ,Endocrinology ,Renal pathology ,Diabetes mellitus ,Internal medicine ,diabetes mellitus ,Internal Medicine ,medicine ,Intensive care medicine ,business ,Nutritional diseases. Deficiency diseases ,chronic kidney disease ,Kidney disease - Abstract
The dramatic increase in the number of patients with diabetes mellitus (DM) and chronic renal disease (CRD) in the recent years emphasizes the closeassociation between the two conditions and the leading role of DM in the development of renal pathology. Diabetology and nephrology are highly costlybranches of public health, and the burden of substitution renal therapy in DM patients continues to grow. The necessity of a renoprotection programat the early stages of DM for the prevention or delay of terminal renal insufficiency becomes increasingly clear. Such program should be based on theconceptual model of the evolvement of diabetic nephropathy as a consequence of combined action of metabolic and hemodynamic factors modulatedby genetic ones.
- Published
- 2011
309. Neue Praxis-Leitlinie DIABETES mellitus Typ 2 in Sachsen – Therapieempfehlungen für Ärzte
- Author
-
Ulrike Rothe, Hans-Joachim Verlohren, Jan Schulze, and Gerhard H. Scholz
- Subjects
Gynecology ,medicine.medical_specialty ,Pediatrics ,business.industry ,Endocrinology, Diabetes and Metabolism ,Internal Medicine ,Type 2 Diabetes Mellitus ,Medicine ,Medical practice ,Diabetology ,business ,Practical guideline - Abstract
Die Fachkommission Diabetes der Sachsischen Landesarztekammer (SLAK) hat mit der Herausgabe der 11. Auflage der Praxis-Leitlinie DIABETES mellitus Typ 2 eine Tradition fortgesetzt, das nationale und internationale Wissen in Therapieempfehlungen fur ambulant und stationar tatige Hausarzte und Diabetologen praxisnah zusammenzufassen. In der neuen Leitlinie wurden neue Studienergebnisse und deren Schlussfolgerungen sorgfaltig und kompetent eingearbeitet. Dabei wird insbesondere auf das Problem der anzustrebenden Stoffwechselqualitat fokussiert: dass es zur normnahen Stoffwechseleinstellung von Anfang an keine Alternative gibt, bei langerer Diabetesdauer risikoabhangige Therapieziele zu formulieren sind, in jedem Fall aber die Blutglukose-Selbstkontrolle notwendig ist, um Patienten vor schweren Hypoglykamien zu schutzen. Im Folgenden werden ausgewahlte Probleme angesprochen, die bei der Implementation der Leitlinien zu beachten sind. The medical specialists' commission for diabetology of the regional chamber of physicians in saxony has issued the 11th edition of the medical practice guidelines for type 2 diabetes mellitus. This continues a long-standing tradition of medical practice-oriented summaries of national and international knowledge of therapeutic recommendations for practising and hospital physicians and diabetologists. The new guidelines include detailed and competent interpretations of novel study results and their relevant conclusions. Emphasis is focussed on the problem of the on-target quality of metabolism and on the fact that there is from the very beginning no alternative to an adjustment to near-normal standards of metabolism and that risk-dependent therapeutic goals must be formulated if the diabetic condition continues to persist for a prolonged period while self-determination of blood glucose levels is always mandatory to protect the patient against severe hypoglycaemias. Selected problems are discussed in the following text which require attention while implementing the guidelines.
- Published
- 2010
310. ISS (Istituto Superiore di Sanità) and AMD (Associazione Medici Diabetologi) – an alliance for the enhancement of telemedicine in diabetology
- Author
-
D. Mannino
- Subjects
Telemedicine ,medicine.medical_specialty ,Alliance ,business.industry ,medicine ,Diabetology ,Medical emergency ,medicine.disease ,business - Published
- 2018
311. DIABETES TIPO 1 E INSULINORRESISTENCIA: TASA ESTIMADA DE DISPOSICIÓN DE LA GLUCOSA Y SU CORRELACIÓN CON COMPLICACIONES CRÓNICAS
- Author
-
Jorge Waitman, Silvana A. Romero Gonzalez, Gabriela Caeiro, and Jimena Itria
- Subjects
medicine.medical_specialty ,Type 1 diabetes ,Waist ,business.industry ,Urology ,nutritional and metabolic diseases ,Insulin sensitivity ,Glucose disposal ,Diabetology ,medicine.disease ,Clinical Practice ,Insulin resistance ,medicine ,General Earth and Planetary Sciences ,In patient ,business ,General Environmental Science - Abstract
Introduction : insulin resistance (IR) in type 1 diabetes (T1D) is associated with a higher risk of complications in these patients. The gold standard for measuring insulin sensitivity is the hyperinsulinemic-euglycemic clamp although not used in clinical practice. The estimated glucose disposal rate (eGDR) has been validated to estimate insulin sensitivity. Objectives : the objective was to correlate IR in T1D (eGDR), with macro and microvascular complications in patients assisted in a Diabetology Service. Materials and methods : we performed a cross-sectional study. The eGDR was calculated using HbA1c, waist circumference, and hypertensive status.
- Published
- 2018
312. Kidney Diseases and Pregnancy: A Multidisciplinary Approach for Improving Care by Involving Nephrology, Obstetrics, Neonatology, Urology, Diabetology, Bioethics, and Internal Medicine
- Author
-
Rossella Attini, Giorgina Barbara Piccoli, and Gianfranca Cabiddu
- Subjects
Nephrology ,medicine.medical_specialty ,nephrology ,030232 urology & nephrology ,lcsh:Medicine ,neonatology ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Diabetes mellitus ,Health care ,medicine ,urology ,Intensive care medicine ,Pregnancy ,Kidney diseases ,obstetrics ,030219 obstetrics & reproductive medicine ,business.industry ,diabetology ,lcsh:R ,Acute kidney injury ,General Medicine ,Bioethics ,medicine.disease ,Editorial ,multidisciplinary approach ,Kidney stones ,pregnancy ,business ,bioethics ,Kidney disease - Abstract
This multidisciplinary series is aimed at offering readers many opportunities to appreciate how a clinical and ethical approach to pregnancy has changed in patients with kidney diseases and with related conditions, including diabetes, hypertension, and immunologic diseases. Furthermore, this series aims to focus on the fact that many issues remain unreslved, that there are enormous gaps in knowledge, and that the bioethical approach needs to integrated in the clinical practice, which would allow for a deeper appreciation of different cultural and religious backgrounds. Much still needs to be done to allow women suffering from all stages of chronic kidney disease (CKD) and those with predisposed conditions, so that they may experience safe pregnancies, starting from an increased awareness of the importance of CKD, even in its early stages, to the detection of risk factors. Women who have experienced preeclampsia or acute kidney injury in pregnancy need to have follow-up checks. The role of urinary infections, kidney stones, and urinary malformations is not fully acknowledged, nor have univocal control schedules and treatment schemas yet been defined for the different kidney diseases. In this regard, the fight for equitable treatment for all women with acute or chronic kidney disease in pregnancy and for the widespread prevention of adverse pregnancy-related and long-term outcomes is ultimately a battle for equitable healthcare.
- Published
- 2018
313. Study on the history of Traditional Chinese Medicine to treat diabetes
- Author
-
Conge Tan, Hongzhan Wang, Shengbo Xue, Hui Zhang, and Miqu Wang
- Subjects
medicine.medical_specialty ,Traditional medicine ,business.industry ,digestive, oral, and skin physiology ,Alternative medicine ,Diabetology ,Effective management ,Traditional Chinese medicine ,Disease ,medicine.disease ,Complementary and alternative medicine ,Basic research ,Family medicine ,Diabetes mellitus ,medicine ,business ,psychological phenomena and processes ,Medical literature - Abstract
Introduction In order to introduce the diabetology history in Traditional Chinese Medicine (TCM), including nomenclature, understanding, treatment, prevention, etc., our research specifically focused on ancient medical literature used in the evaluation of diabetes in TCM or wasting-thirst (xiao-ke). Methodology The history of wasting-thirst was classified into four periods: (1) the nomenclature of wasting-thirst; (2) the monograph of wasting-thirst; (3) the understandings of sweet urine and its extensive development; and (4) the integration of wasting-thirst and diabetes. Results By mining and reviewing the literature in the 2000-year history of wasting-thirst, it is believed that TCM has a profound understanding of, and effective management on, diabetes and its complications. For period one, wasting-thirst was first recorded in The Yellow Emperor's Classic of Internal Medicine. For period two, it was elaborated in Treatise on Febrile and Miscellenous Disease, and its “pathology” was summarized as “three wasting-thirsts (upper, middle, lower)” from the perspectives of spatial locations of organs, which serves as a guide in clinical practice. For period three, a self-contained system, including diagnosis, treatment, prevention, nursing, and education, had been established. For period four, wasting-thirst was intimately integrated into diabetes in The Integration of Traditional Chinese Medicine and Western Medicine. Discussion Traditional Chinese Medicine harbors a long history of treating wasting-thirst/diabetes. With its unique therapeutic approaches, TCM is an effective system of understanding and managing diabetes as proven by medical literatures, clinical benefits and basic research studies.
- Published
- 2010
314. Conference Scene: The 4th Asian Congress on Autoimmunity
- Author
-
Neeraj Kumar and Narinder K. Mehra
- Subjects
medicine.medical_specialty ,business.industry ,Systemic lupus ,education ,Immunology ,Alternative medicine ,Diabetology ,Autoimmune hepatitis ,medicine.disease ,medicine.disease_cause ,humanities ,Rheumatology ,Autoimmunity ,Oncology ,Treatment modality ,Internal medicine ,Family medicine ,Immunology and Allergy ,Medicine ,Type i diabetes ,business ,health care economics and organizations - Abstract
The 4th Asian Congress on Autoimmunity was held in Suntec City, Singapore from September 11–13, 2009. The congress was addressed by senior investigators in the field of autoimmunity, rheumatology, immunology and diabetology. Yehuda Shoenfeld and his colleagues put together a vibrant scientific program with focus on the pathogenesis, genetics, mechanisms and clinical aspects of the autoimmune diseases and their treatment modalities. Rheumatoid arthritis, systemic lupus erythmetosus, Type I diabetes and autoimmune hepatitis were the main diseases that were discussed by the various scientists, not only from Asia but also from other parts of the world.
- Published
- 2010
315. Age and Sex Influence Mitochondria and Cardiac Health in Offspring Exposed to Maternal Glucolipotoxicity.
- Author
-
Louwagie EJ, Larsen TD, Wachal AL, Gandy TCT, Eclov JA, Rideout TC, Kern KA, Cain JT, Anderson RH, Mdaki KS, and Baack ML
- Abstract
Infants of diabetic mothers are at risk of cardiomyopathy at birth and myocardial infarction in adulthood, but prevention is hindered because mechanisms remain unknown. We previously showed that maternal glucolipotoxicity increases the risk of cardiomyopathy and mortality in newborn rats through fuel-mediated mitochondrial dysfunction. Here we demonstrate ongoing cardiometabolic consequences by cross-fostering and following echocardiography, cardiomyocyte bioenergetics, mitochondria-mediated turnover, and cell death following metabolic stress in aged adults. Like humans, cardiac function improves by weaning with no apparent differences in early adulthood but declines again in aged diabetes-exposed offspring. This is preceded by impaired oxidative phosphorylation, exaggerated age-related increase in mitochondrial number, and higher oxygen consumption. Prenatally exposed male cardiomyocytes have more mitolysosomes indicating high baseline turnover; when exposed to metabolic stress, mitophagy cannot increase and cardiomyocytes have faster mitochondrial membrane potential loss and mitochondria-mediated cell death. Details highlight age- and sex-specific roles of mitochondria in developmentally programmed adult heart disease., Competing Interests: The authors declare no competing interests., (© 2020 The Author(s).)
- Published
- 2020
- Full Text
- View/download PDF
316. BCG Vaccinations Upregulate Myc, a Central Switch for Improved Glucose Metabolism in Diabetes.
- Author
-
Kühtreiber WM, Takahashi H, Keefe RC, Song Y, Tran L, Luck TG, Shpilsky G, Moore L, Sinton SM, Graham JC, and Faustman DL
- Abstract
Myc has emerged as a pivotal transcription factor for four metabolic pathways: aerobic glycolysis, glutaminolysis, polyamine synthesis, and HIF-1α/mTOR. Each of these pathways accelerates the utilization of sugar. The BCG vaccine, a derivative of Mycobacteria-bovis, has been shown to trigger a long-term correction of blood sugar levels to near normal in type 1 diabetics (T1D). Here we reveal the underlying mechanisms behind this beneficial microbe-host interaction. We show that baseline glucose transport is deficient in T1D monocytes but is improved by BCG in vitro and in vivo. We then show, using RNAseq in monocytes and CD4 T cells, that BCG treatment over 56 weeks in humans is associated with upregulation of Myc and activation of nearly two dozen Myc-target genes underlying the four metabolic pathways. This is the first documentation of BCG induction of Myc and its association with systemic blood sugar control in a chronic disease like diabetes., Competing Interests: Declaration of Interests The authors declare no competing interests., (Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
317. Sodium-glucose co-transporter 2 inhibitors and diabetic retinopathy: insights into preservation of sight and looking beyond.
- Author
-
Lahoti S, Nashawi M, Sheikh O, Massop D, Mir M, and Chilton R
- Abstract
Sodium-glucose co-transporter 2 Inhibitors (SGLT2i) were initially developed as therapeutic options for patients with type 2 diabetes mellitus (T2DM). Recently, randomized clinical trials have investigated their effects in cardiorenal protection through major adverse cardiovascular event reduction and reductions in diabetic nephropathy. While multiple mechanisms are proposed for this protection, microvascular protection is the primary component of their efficacy. While not primarily emphasized in clinical trials, evidence in other studies suggests that SGLT2i may confer retinoprotective effects via some of the same mechanisms in the aforementioned cardiorenal trials. Diabetic patients are susceptible to vision loss with chronic hyperglycemia promoting inflammation, edema, and retinal pathological changes. Targeting these pathways via SGLT2i may represent opportunities for providers to decrease retinopathy in high-risk T2DM patients, reduce disease progression, and lower drug burden in diabetic retinopathy patients. Further comprehensive clinical trials investigating these associations are needed to establish the potential retinoprotective effects of SGLT2i., (Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
318. The systemic implication of novel non-statin therapies in cardiovascular diabetology: PCSK9 as a case model.
- Author
-
Nashawi M, Sheikh O, Mir M, Te T, and Chilton R
- Abstract
PCSK9, like other novel non-statin drugs were primarily developed to help patients achieve low-density lipoprotein cholesterol targets, especially in patients with dyslipidemia not achieving lipid goals with statins due to poor tolerance or inadequate response. PCSK9 inhibitors, in addition to modulating lipid metabolism, improve mortality outcomes in cardiovascular disease. These benefits are markedly pronounced in patients with type 2 diabetes mellitus. However, these benefits do not come without associated risk. Multiple trials, studies, and case reports have attempted to explain observed outcomes with PCSK9 expression and administration of PCSK9 inhibitors from multiple perspectives, such as their effects on insulin sensitivity and glucose tolerance, changes in renal physiology, thyroid physiology, vascular tone, intestinal regulation of lipids, and improved cardiovascular function. These agents represent an opportunity for physicians to exercise prudence by using appropriate clinical judgement when managing comorbidities in the hyperglycemic patient, a concept that extends to other novel non-statin drugs., (Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
319. Obesity Reshapes Visceral Fat-Derived MHC I Associated-Immunopeptidomes and Generates Antigenic Peptides to Drive CD8 + T Cell Responses.
- Author
-
Chen X, Wang S, Huang Y, Zhao X, Jia X, Meng G, Zheng Q, Zhang M, Wu Y, and Wang L
- Abstract
Adaptive CD8
+ T cells were observed to contribute to the initiation and progression of obesity-induced visceral adipose tissue (VAT) chronic inflammation that is critically linked to metabolic disorders. Numerous peptides presented by the major histocompatibility complex (MHC) class I molecules at the cell surface are collectively termed as MHC I-associated immunopeptidome (MIP) for the interaction with CD8+ T cells. We conducted the in-depth mapping of MIP of VAT from lean and obese mice using large-scale high-resolution mass spectrometry and observed that obesity significantly alters the landscape of VAT MIPs. Additionally, the obese VAT-exclusive MIP source proteome reflected a distinct obesity-associated signature. A peptide derived from lactate dehydrogenase A (LDHA) or B chain, named LDHA237-244 , was identified as an obese VAT-exclusive immunogenic peptide that was capable of eliciting pro-inflammatory CD8+ T cells responses. Our findings suggest that certain immunogenic peptides generated by obesity may trigger CD8+ T cell-mediated VAT inflammation., Competing Interests: Declaration of Interests The authors declare no competing interests., (Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF
320. EDEM3 Modulates Plasma Triglyceride Level through Its Regulation of LRP1 Expression.
- Author
-
Xu YX, Peloso GM, Nagai TH, Mizoguchi T, Deik A, Bullock K, Lin H, Musunuru K, Yang Q, Vasan RS, Gerszten RE, Clish CB, Rader D, and Kathiresan S
- Abstract
Human genetics studies have uncovered genetic variants that can be used to guide biological research and prioritize molecular targets for therapeutic intervention for complex diseases. We have identified a missense variant (P746S) in EDEM3 associated with lower blood triglyceride (TG) levels in >300,000 individuals. Functional analyses in cell and mouse models show that EDEM3 deficiency strongly increased the uptake of very-low-density lipoprotein and thereby reduced the plasma TG level, as a result of up-regulated expression of LRP1 receptor. We demonstrate that EDEM3 deletion up-regulated the pathways for RNA and endoplasmic reticulum protein processing and transport, and consequently increased the cell surface mannose-containing glycoproteins, including LRP1. Metabolomics analyses reveal a cellular TG accumulation under EDEM3 deficiency, a profile consistent with individuals carrying EDEM3 P746S. Our study identifies EDEM3 as a regulator of blood TG, and targeted inhibition of EDEM3 may provide a complementary approach for lowering elevated blood TG concentrations., Competing Interests: Declaration of Interests The authors declare no competing interests., (Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
321. Exposure of Pancreatic β-Cells to Excess Glucose Results in Bimodal Activation of mTORC1 and mTOR-Dependent Metabolic Acceleration.
- Author
-
Rumala CZ, Liu J, Locasale JW, Corkey BE, Deeney JT, and Rameh LE
- Abstract
Chronic exposure of pancreatic β-cells to excess glucose can lead to metabolic acceleration and loss of stimulus-secretion coupling. Here, we examined how exposure to excess glucose (defined here as concentrations above 5 mM) affects mTORC1 signaling and the metabolism of β-cells. Acute exposure to excess glucose stimulated glycolysis-dependent mTORC1 signaling, without changes in the PI3K or AMPK pathways. Prolonged exposure to excess glucose led to hyperactivation of mTORC1 and metabolic acceleration, characterized by higher basal respiration and maximal respiratory capacity, increased energy demand, and enhanced flux through mitochondrial pyruvate metabolism. Inhibition of pyruvate transport to the mitochondria decelerated the metabolism of β-cells chronically exposed to excess glucose and re-established glucose-dependent mTORC1 signaling, disrupting a positive feedback loop for mTORC1 hyperactivation. mTOR inhibition had positive and negative impacts on various metabolic pathways and insulin secretion, demonstrating a role for mTOR signaling in the long-term metabolic adaptation of β-cells to excess glucose., Competing Interests: Declaration of Interests The Authors declare no competing interests., (Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
322. Islet Macrophages Shift to a Reparative State following Pancreatic Beta-Cell Death and Are a Major Source of Islet Insulin-like Growth Factor-1.
- Author
-
Nackiewicz D, Dan M, Speck M, Chow SZ, Chen YC, Pospisilik JA, Verchere CB, and Ehses JA
- Abstract
Macrophages play a dynamic role in tissue repair following injury. Here we found that following streptozotocin (STZ)-induced beta-cell death, mouse islet macrophages had increased Igf1 expression, decreased proinflammatory cytokine expression, and transcriptome changes consistent with macrophages undergoing efferocytosis and having an enhanced state of metabolism. Macrophages were the major, if not sole, contributors to islet insulin-like growth factor-1 (IGF-1) production. Adoptive transfer experiments showed that macrophages can maintain insulin secretion in vivo following beta-cell death with no effects on islet cell turnover. IGF-1 neutralization during STZ treatment decreased insulin secretion without affecting islet cell apoptosis or proliferation. Interestingly, high-fat diet (HFD) combined with STZ further skewed islet macrophages to a reparative state. Finally, islet macrophages from db/db mice also expressed decreased proinflammatory cytokines and increased Igf1 mRNA. These data have important implications for islet biology and pathology and show that islet macrophages preserve their reparative state following beta-cell death even during HFD feeding and severe hyperglycemia., Competing Interests: Declaration of Interests The authors declare no competing interests., (Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
323. Determinants of Vitamin D Supplementation among Individuals with Type 1 Diabetes.
- Author
-
Kamiński M, Molenda M, Banaś A, Uruska A, and Zozulińska-Ziółkiewicz D
- Subjects
- Adult, Cross-Sectional Studies, Female, Humans, Male, Poland, Young Adult, Diabetes Mellitus, Type 1 complications, Dietary Supplements, Vitamin D administration & dosage, Vitamin D Deficiency therapy
- Abstract
Half of the individuals with type 1 diabetes (T1DM) may present Vitamin D (VD) deficiency. There is little known about factors determining a decision on VD supplementation. The study aimed to determine the factors affecting vitamin D supplementation in people with T1DM. A cross-sectional survey study using the authors' questionnaire paper and its digital version was performed. The questions involved data on the basic characteristics of the respondent, medical history, VD supplementation status, influence of the social environment, self-education, and the most important personal motivator for VD supplement use. Multivariate logistic regression analysis was performed. We collected a total of n = 184 papers and n = 550 digital complete surveys. From 734 total respondents, 62.0% declared VD supplementation. The main personal rationale for VD supplementation were recommendation of medical specialist 172 (37.8%) and self-education 135 (29.7%). The main reasons for non-supplementation of VD were lack of knowledge about VD 159 (57.0%) and lack of motivation 77 (27.6%). VD supplementation was independently associated with a family doctor (odds ratio (OR), 95% confidence interval (CI): 4.67, 2.32-9.40) or medical specialist recommendation (16.20, 9.57-27.43), and self-education (5.97, 3.90-9.13). Most Polish individuals with T1DM use VD supplements, and the decision is related to physicians' recommendations and self-education., Competing Interests: The authors declare no conflict of interest.
- Published
- 2020
- Full Text
- View/download PDF
324. Versorgungssituation von Patienten mit Diabetes mellitus an deutschen Krankenhäusern – Strategien eines adäquaten Struktur– und Prozessmanagements
- Author
-
Erhard Siegel and Manfred Dreyer
- Subjects
medicine.medical_specialty ,Pediatrics ,Hospitalized patients ,business.industry ,Diabetology ,General Medicine ,medicine.disease ,Care personnel ,Diabetes model ,Treatment quality ,Concomitant ,Diabetes mellitus ,medicine ,Intensive care medicine ,business ,Competence (human resources) - Abstract
To date, data on the prevalence of diabetes mellitus in German hospitals have been insufficient. A several-years' study (Ludwigshafen-Limburg Diabetes Model Study) revealed definitely a prevalence of approximately 30 % as well as 75 % confirmed subsequent complications in all hospitalized patients. Hence, diabetes mellitus is one of the most frequent concomitant diseases of in-patients. Actually, however, the concomitant diagnosis ”diabetes mellitus” has so far been established in only 10 % of all in-patients and the subsequent complications have been recognized in only 10 % of these. Diabetic patients hospitalized as emergency cases for other reasons are definite safety risks that have so far hardly been recognized or systematically recorded as diabetics. Treatment quality can be improved by adequate structural and process management and the in-hospital period significantly reduced and cost saved. Adequate CCL-relevant coding can contribute to a considerable saving of cost. These structures can be effectively translated into reality only by means of qualified diabetology and super-departmentological competence without any departmentally defined restrictions. A structurally defined management of diabetes must be available for treating these patients. This management set-up must include inter alia an adequate training of the physicians and care personnel as well as algorithms for treatment in a variety of situations. This specific procedural catalog is being presented all over Germany in on-target multiprofessional management seminars (DEC seminars). Among others, specifically the German Hospitals Society and the cost-bearers are addressed to realize adequate structures.
- Published
- 2009
325. Status quo Gastroenterologie
- Author
-
D. Kühne, Katarina Dathe, Markus M. Lerch, M. L. Hermans, J. F. Riemann, G. Gerken, Birkner B, Wolfgang Schepp, and Rudolf Arnold
- Subjects
Geriatrics ,medicine.medical_specialty ,Private practice ,business.industry ,Capsule endoscopy ,law ,Internal medicine ,Gastroenterology ,medicine ,Diabetology ,business ,law.invention - Abstract
In future, the profile of gastroenterology in Germany - as in other countries - will change. New achievements such as capsule endoscopy, aero-scopes and advanced CT and MRI technology and others will become alternatives to conventional endoscopy. Additional emphasis in clinical and outpatient gastroenterology is shifted towards gastrointestinal oncology, dietetics, nutrition and metabolism and in the clinical setting onto infectious diseases, endocrinology/diabetology, intensive care medicine, emergency service and geriatric medicine. The German Confederation of Gastroenterology (BVGD) initiated two Germany-wide surveys on the current diagnostic and therapeutic spectrum in hospitals and out-patient facilities to achieve a base for future discussions regarding the development of gastroenterology. The number of gastroenterologists working in hospitals and in out-patient facilities has been analysed as well as the number of examinations passed successfully during the last few years in the speciality "gastroenterology". The results of this survey offer a valid basis for continuing discussions as to how gastroenterology should develop in Germany.
- Published
- 2009
326. Foxo in T Cells Regulates Thermogenic Program through Ccr4/Ccl22 Axis.
- Author
-
Kikuchi T, Nakae J, Kawano Y, Watanabe N, Onodera M, and Itoh H
- Abstract
Crosstalk between immunity and the thermogenic program has provided insight into metabolic energy regulation. Here, we generated thermogenic program-accelerating mice (T-QKO), in which Foxo1 is knockout and Foxo3 is hetero-knockout in CD4
+ T cells. T-QKO exhibit lean phenotype under HFD due to increased energy expenditure. Cold exposure significantly increased expression of the thermogenic genes (Ppargc1a and Ucp1), Th2 cytokines (Il4 and Il13), and Th2 marker gene (Gata3) in subcutaneous adipose tissue (SC) of T-QKO. Furthermore, Ccr4 expression was significantly increased in Th2 cells of T-QKO, and cold exposure induced Ccl22 expression in SC, leading to increased accumulation of Th2 cell population in SC of T-QKO. These data reveal a mechanism by which cold exposure induces selective recruitment of Th2 cells into SC, leading to regulation of energy expenditure by generating beige adipocyte and suggest that inhibition of Foxo in T cells may support a strategy to prevent and treat obesity., (Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
327. Dietary therapy in diabetic pregnancy: recommendations
- Author
-
Giuseppe Pipicelli, Annunziata Lapolla, Mario Parillo, Sergio Leotta, Giuseppe Fatati, Graziano Di Cianni, and Domenico Mannino
- Subjects
medicine.medical_specialty ,Pregnancy ,Nutrition and Dietetics ,business.industry ,Endocrinology, Diabetes and Metabolism ,Diabetology ,medicine.disease ,Endocrinology ,Diabetes mellitus ,Family medicine ,Internal medicine ,Medicine ,Medical nutrition therapy ,Dietary therapy ,business ,Diabetic pregnancy ,Food Science - Abstract
As a further elaboration of our systematic definition of nutritional therapy in diabetic patients, this booklet looks at the delicate but very important question of the diabetic woman’s diet during pregnancy. The recommendations were drafted by diabetologists and nutritionists who have specifically studied the problems of nutrition in pregnancy, and are backed by the Italian Association for Clinical Dietetics and Nutrition (ADI), the Association of Medical Diabetologists (AMD), and the Italian Society for Diabetology (SID). The synergism of this joint effort has produced a document that we sincerely hope will help all members of teams who tackle this vital issue in diabetes in their daily work.
- Published
- 2008
328. Population pharmacokinetics of metformin in obese and non-obese patients with type 2 diabetes mellitus
- Author
-
Bardin, Christophe, Nobecourt, Estelle, Larger, Etienne, Chast, François, Treluyer, Jean-Marc, and Urien, Saik
- Published
- 2012
- Full Text
- View/download PDF
329. Gastrointestinal autonomic neuropathy in diabetes: the unattended borderline between diabetology and gastroenterology
- Author
-
Péter Kempler, V Horvath, Tamás Várkonyi, and Anna Erzsébet Körei
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Diabetic neuropathy ,Gastroparesis ,Endocrinology, Diabetes and Metabolism ,030209 endocrinology & metabolism ,Autonomic Nervous System ,Gastroenterology ,03 medical and health sciences ,0302 clinical medicine ,Diabetic Neuropathies ,Internal medicine ,Diabetes mellitus ,Internal Medicine ,medicine ,Humans ,business.industry ,Diabetology ,Human physiology ,medicine.disease ,Diabetic enteropathy ,Autonomic nervous system ,030104 developmental biology ,Diabetes Mellitus, Type 1 ,Autonomic Nervous System Diseases ,Autonomic neuropathy ,business - Published
- 2015
330. Progetto ABC. Achieved Best Cholesterol
- Author
-
Augusto Zaninelli, Stefano Urbinati, and Pasquale Perrone Filardi
- Subjects
medicine.medical_specialty ,business.industry ,Primary prevention ,Text messaging ,Medicine ,Diabetology ,business ,Humanities - Abstract
The ABC project is based on the drafting of 130 clinical cases on the theme of dyslipidemia in men and women, coming from university and hospital Internal Medicine and/or Diabetology Operating Units. The cases are selected with the aim of clearly representing the Italian reality. The drafting of the cases is articulated in the compilation of mandatory and free text fields, within a pre-established form: this has allowed a global analysis of the aggregated data, making it possible to obtain a real picture of the clinical features, risk factors, diagnostic investigations and therapeutic setting of patients who usually address the Italian clinical lipidologist for the problems of hypercholesterolaemia and of the target values to achieve in primary prevention, in high-risk patients, as well as in secondary prevention.Il progetto ABC si basa sulla redazione di 130 casi clinici sul tema della dislipidemia nel genere maschile e in quello femminile, provenienti da Unita Operative di Medicina Interna e/o Diabetologia, sia ospedaliere, sia universitarie, assolutamente rappresentativi della realta nazionale. La redazione dei casi si articola nella compilazione di campi obbligatori e a testo libero, all’interno di un form prestabilito: cio ha consentito un’analisi globale dei vari dati aggregati, permettendo di ottenere una vera e propria fotografia delle caratteristiche cliniche, dei fattori di rischio, delle indagini diagnostiche e dell’impostazione terapeutica dei pazienti che abitualmente afferiscono al lipidologo clinico italiano per il problema della ipercolesterolemia e dei valori target da raggiungere sia in prevenzione primaria, nel paziente ad alto rischio, sia in quella secondaria.
- Published
- 2015
331. Reviewer acknowledgement 2014
- Author
-
Daniel Giannella-Neto
- Subjects
medicine.medical_specialty ,business.industry ,Reviewer Acknowledgement ,Family medicine ,Endocrinology, Diabetes and Metabolism ,Acknowledgement ,Internal Medicine ,Medicine ,Diabetology ,Editorial board ,business - Abstract
Contributing reviewers The Editors of Diabetology & Metabolic Syndrome would like to thank all of our reviewers, both external and Editorial Board Members, who have contributed to the journal in Volume 6 (2014) and whose valuable support is fundamental to the success of the journal.
- Published
- 2015
332. A training course for experts in diabetology in primary care
- Author
-
Huberta E. Hart and Guy E.H.M. Rutten
- Subjects
Adult ,Male ,medicine.medical_specialty ,Quality management ,media_common.quotation_subject ,Training course ,Endocrinology, Diabetes and Metabolism ,Primary care ,Physicians, Primary Care ,Endocrinology ,Ambulatory care ,Nursing ,General Practitioners ,Health care ,Diabetes Mellitus ,Internal Medicine ,Journal Article ,Humans ,Medicine ,Netherlands ,Quality Indicators, Health Care ,media_common ,Medicine(all) ,Nutrition and Dietetics ,Primary Health Care ,Delegation ,business.industry ,Diabetology ,Middle Aged ,Quality Improvement ,Diabetes and Metabolism ,Diabetes Care Groups ,Education, Medical, Continuing ,Female ,Clinical Competence ,Curriculum ,Family Practice ,business - Abstract
In the Netherlands so-called Diabetes Care Groups organize the primary diabetes care centrally with delegation to different health care providers. A training course for general practitioners who would like to become experts in diabetology in the primary care setting meets the need to guide the quality management processes in these care groups.
- Published
- 2015
333. Éducation des maladies chroniques en cardiologie au sein d’une unité transversale d’éducation multidisciplinaire : expérience d’un centre hospitalier général
- Author
-
V. Averous, E. Maetz, P. Joly, S. Madoun, G. Prévost, O. Jaboureck, S. Racoussot, J.-J. Dujardin, D. Dervaux, and R. Bresson
- Subjects
medicine.medical_specialty ,Patient care team ,business.industry ,Diabetology ,medicine.disease ,Unit (housing) ,Surgery ,Chronic disease ,Quality of life (healthcare) ,medicine ,Medical emergency ,General hospital ,Cardiology and Cardiovascular Medicine ,Human resources ,business - Abstract
Treatments for congestive heart failure, hypertension and cardiovascular risk have significantly changed and have become more complex. The have also become more and more effective thanks to the results of great clinical studies that have enabled European and North-American societies to issues recommendations. The observance of the pharmacological and non-pharmacological treatments requires the education of patients and their family following guidelines that have been clearly defined by the European Society of Cardiology. This education, in which the technic of communication is very important, is common to a lot of chronic diseases and requires adequate material and human resources in order to have an optimal quality of treatment. In a society in which spending is on rise, getting such resources is not easy. However, putting in common resources of several departments can be a good solution. The experience of the Hospital Center of Douai (France) lead to the creation of a Transversal Education Unit at the end of the year 2003. This unit centralizes the efforts of several departments of care like pneumology, pediatrics, diabetology, nutrition and cardiology and allows patients suffering from co-morbidities to have access to various programs of this unit.
- Published
- 2005
334. Corrigendum to 'BCL11B, FLT3, NOTCH1 and FBXW7 mutation status in T-cell acute lymphoblastic leukemia patients' [Blood Cells Mol. Dis. 50 (2013) 33–38]
- Author
-
Maria Kosmalska, Monika D. Kraszewska, Łukasz Sędek, Tomasz Szczepański, Jerzy Kowalczyk, Małgorzata Dawidowska, Michał Witt, and Władysław Grzeszczak
- Subjects
medicine.medical_specialty ,business.industry ,Lymphoblastic Leukemia ,Diabetology ,social sciences ,Cell Biology ,Hematology ,humanities ,Internal medicine ,Immunology ,otorhinolaryngologic diseases ,medicine ,Molecular Medicine ,Medical genetics ,Pediatric hematology ,business ,Molecular Biology ,geographic locations - Abstract
a Department of Molecular and Clinical Genetics, Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland b Department of Pediatric Hematology and Oncology, Medical University of Silesia, Zabrze, Poland c Department of Internal Diseases, Diabetology and Nephrology, Medical University of Silesia, Zabrze, Poland d Department of Pediatric Hematology and Oncology, Medical University, Lublin, Poland e International Institute of Molecular and Cell Biology, Warsaw, Poland
- Published
- 2013
335. The specificity of medical facts: the case of diabetology
- Author
-
Christiane Sinding
- Subjects
History ,Politics ,medicine.medical_specialty ,History and Philosophy of Science ,Philosophy ,medicine ,Diabetology ,General Medicine ,History of medicine ,Social constructivism ,Historical study ,Epistemology - Abstract
The fact that Ludwik Fleck drew his inspiration from medicine has been largely overlooked, with the exception of a few scholars. Although Fleck considered his ideas applicable to all sciences, he always insisted on the specificity of medicine. To illustrate the usefulness of Fleck’s concepts for the history of medicine, three main ideas developed by Fleck are applied to the historical study of diabetes mellitus (DM): first, that different and often divergent pictures of disease coexist within a given culture; second, that scientific ideas circulate between ‘esoteric’ and ‘exoteric’ circles; and third, that scientific concepts are often incommensurable. The author also suggests that Fleck’s epistemology, like other scholars’, is loaded with ethical and political consequences. However, the link between an ‘open’ epistemology and political or ethical questions is more explicit in Georges Canguilhem’s pioneering work on the normal and the pathological (1943). Indeed, Canguilhem and Fleck’s conceptions of disease have much in common, so that we can use Canguilhem’s work to bring out the hidden ethical and political issues in Fleck’s work.
- Published
- 2004
336. Übergangssprechstunden für chronisch Kranke in Endokrinologie und Diabetologie in Deutschland
- Author
-
M Lausch and M Reincke
- Subjects
medicine.medical_specialty ,Teamwork ,Pediatrics ,business.industry ,media_common.quotation_subject ,digestive, oral, and skin physiology ,Attendance ,Diabetology ,General Medicine ,Adult care ,University hospital ,Medical care ,Patient satisfaction ,Family medicine ,Medicine ,business ,Patient compliance ,media_common - Abstract
BACKGROUND AND OBJECTIVES: Transferring adolescent patients with endocrine disorders from paediatric to adult care units depends on regional facilities with varying efficiency. A nationwide system of transition clinics in Germany is actually not available, despite demands by physicians and patients. PATIENTS AND METHODS: We conducted a survey for the 36 German university hospitals to examine the regional existence and characteristics of actual transition methods. In a second questionnaire patients were asked to report their individual transition periods. RESULTS: Despite physician's demand in the majority of hospitals, there are only eight transition clinics nationwide. On average 56 patients attended these clinics yearly. Most patients suffered from disorders of pituitary, thyroid or adrenal gland (each 76 %) and diabetes mellitus type 1 (82 %). The perception of teamwork between the paediatric and adult care units was better in hospitals with transition clinics. Moreover, there was more scientific cooperation in those hospitals. Attendance to medical care and patient's compliance was enhanced by establishing transition clinics in 82 % and 70 %, respectively. Questioning affected patients we found attendance to the paediatric team up to the age of twenty with substantial difficulties finding an adequate adult care unit. Patients were more contend with paediatric than adult quality of physicians care (mark 1.6 versus 2.4). 82 % of patients judged establishing transition clinics as "urgently needed". CONCLUSION: In conclusion there are transition clinics in one quarter of German university hospitals. A more widespread installation of transition clinics is medical reasonable and is demanded by patients.
- Published
- 2004
337. GDF-15, soluble ST2 and Troponin-I: Biomarkers of Subclinical Vascular Disease?
- Author
-
Andreas Tomaschitz, Stefan Pilz, and Winfried März
- Subjects
medicine.medical_specialty ,business.industry ,Diabetology ,Chemical laboratory ,030204 cardiovascular system & hematology ,Bioinformatics ,Article ,03 medical and health sciences ,0302 clinical medicine ,Family medicine ,medicine ,University medical ,Cardiology and Cardiovascular Medicine ,Vascular function ,business ,030217 neurology & neurosurgery - Abstract
a Specialist Clinic for Rehabilitation Bad Aussee, Bad Aussee, Austria b Department of Cardiology, Medical University of Graz, Graz, Austria c Department of Internal Medicine, Division of Endocrinology and Metabolism, Medical University of Graz, Graz, Austria d Department of Epidemiology and Biostatistics, EMGO Institute for Health and Care Research, VU University Medical Center, 1081 BT Amsterdam, The Netherlands e Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria f Synlab Academy, Synlab Services LLC, Mannheim, Germany g Vth Department of Medicine (Nephrology, Hypertensiology, Endocrinology, Diabetology, Rheumatology), Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany
- Published
- 2016
338. Diabetology for cardiologists
- Author
-
Markku Laakso and Johanna Kuusisto
- Subjects
medicine.medical_specialty ,business.industry ,Diabetology ,Disease ,Type 2 diabetes ,medicine.disease ,Coronary heart disease ,Internal medicine ,Diabetes mellitus ,Cardiac complication ,medicine ,Cardiology ,Cardiology and Cardiovascular Medicine ,business ,Intensive care medicine - Abstract
The number of diabetic people will be doubled worldwide in the following 10 years, due to an increase in the number of type 2 diabetic patients. Because type 2 diabetes increases the risk for cardiovascular disease by two- to fourfold, cardiovascular complications will become a major health problem. This review will focus on definition, classification and diagnostic criteria for diabetes, risk factors for type 2 diabetes, macrovascular complications of diabetes, and prevention and treatment of coronary heart disease in type 2 diabetic patients.
- Published
- 2003
339. Joint ESC/EASD Guidelines on Diabetes, where are we Now and where should we Go?
- Author
-
Linda Mellbin and Lars Rydén
- Subjects
Pharmacology ,medicine.medical_specialty ,Evidence-Based Medicine ,business.industry ,MEDLINE ,Cardiovascular Agents ,Diabetology ,Evidence-based medicine ,Diabetes mellitus therapy ,medicine.disease ,Diabetes Complications ,Prediabetic State ,Management strategy ,Cardiovascular Diseases ,Diabetes mellitus ,Practice Guidelines as Topic ,Diabetes Mellitus ,medicine ,Humans ,Hypoglycemic Agents ,Prediabetes ,Cardiology and Cardiovascular Medicine ,business ,Intensive care medicine ,Risk Reduction Behavior - Abstract
Patients with diabetes and prediabetes are at high risk for micro- and macrovascular complications. A multifactorial management strategy improves their prognosis considerably. Of concern is that these patients often fall between two specialties: cardiovascular medicine and diabetology. Practice guidelines for this patient category have been issued in collaboration between the European Society of Cardiology and the European Association for the Study of Diabetes to ascertain management according to the best available evidence. This article discusses why and for whom such guidelines are important.
- Published
- 2012
340. Regulation of medical devices used in diabetology in Europe: Time for reform?
- Author
-
S. Del Prato and Andrew J.M. Boulton
- Subjects
Male ,Spontaneous rupture ,medicine.medical_specialty ,Equipment Safety ,business.industry ,Endocrinology, Diabetes and Metabolism ,Medical practice ,Diabetology ,medicine.disease ,Diabetes treatment ,Clinical diabetes ,Device Usage ,Europe ,Diabetes Mellitus, Type 1 ,Equipment and Supplies ,Device Approval ,Internal Medicine ,medicine ,Physical therapy ,Humans ,Female ,European commission ,Medical emergency ,business ,Medical literature - Abstract
To the Editor: A series of high-profile failures of medical devices in recent years has resulted in much debate in Europe as to the approval process and subsequent regulation of devices used in medical practice [1, 2]. Such is the concern about the perceived lack of regulation and monitoring of devices that barely a week has passed in early 2012 without reports or comments on device failures in the medical literature. These have ranged from the spontaneous rupture of Poly Implant Prosthese (PIP; La Seyne-sur-Mer, France) silicone gel breast implants [3] and the dangers of metal on metal hip implants [4, 5], to deaths caused by the likely failure of implantable cardioverter–defibrillator leads [6, 7]. Fortunately, to date and to our knowledge, such serious failures have not been reported for devices used in the management of patients with diabetes. However, faced with the rapid increase of device usage in the treatment of diabetes, the EASD earlier this year hosted a meeting of interested parties from the diabetes associations, industry, academia and the European Commission to discuss European perspectives on medical devices used in diabetes [8]. In this letter, we review the usage of devices in diabetes treatment, describe the current European regulations for device registration and monitoring, and outline the urgent need for reform of the entire process.
- Published
- 2012
341. The Era of Enlightenment Ends with the Golden Calf
- Author
-
Michael Berger
- Subjects
medicine.medical_specialty ,Psychoanalysis ,business.industry ,media_common.quotation_subject ,Medicine ,Enlightenment ,Diabetology ,Golden calf ,General Medicine ,business ,media_common - Abstract
the practice of medicine was largely based upon witchcraft and voodooism. Let me present you an example from my own discipline, diabetology. The military surgeon John Rollo is usually being praised as the father of modern diabetes care. In 1798, he published a monography which was to become the basis for his fame [12]. It contains the detailed description of the sad case history of Captain Meredith who had presented himself with Type 2 diabetes and its usual symptoms. Dr. Rollo tortured the poor patient to death using some of absolutely absurd dietary and surgical therapies. Why did the poor patient accept such an absurd treatment? Maybe it is explained because the doctor-patient interaction took place within the world of the
- Published
- 2002
342. The MODY Type of Diabetes Mellitus
- Author
-
Carolina S. V. Oliveira, André F. Reis, and Gilberto K. Furuzawa
- Subjects
Genetics ,medicine.medical_specialty ,Glucokinase ,business.industry ,Fatores de transcrição ,Endocrinology, Diabetes and Metabolism ,Type 2 Diabetes Mellitus ,Diabetology ,General Medicine ,medicine.disease ,Genética ,Glicoquinase ,Diabetes mellitus ,MODY ,Mutation (genetic algorithm) ,Transcription factors ,medicine ,Genetic predisposition ,business ,High penetrance ,Systematic search - Abstract
Estima-se que perto de 5% dos indivíduos classificados como portadores de diabetes mellitus (DM) tipo 2 e 10% daqueles considerados como tipo 1 (anteriormente classificado como juvenil) sejam, na verdade, portadores de mutações MODY. Nesta forma de DM ocorre uma co-segregação evidente de algumas mutações com a hiperglicemia, fato este reproduzido em inúmeras famílias estudadas em várias populações do mundo. Caracteriza-se por ser uma das poucas causas de DM cujo modo de transmissão da predisposição genética ocorre de uma forma autossômica-dominante, compondo o grupo chamado de DM monogênicos, onde os outros representantes têm uma prevalência bastante rara. As mutações nos genes MODY, mesmo no estado heterozigoto, apresentam um forte impacto no fenótipo (alta penetrância), sendo que 95% dos indivíduos nascidos com alguma mutação MODY serão diabéticos ou apresentarão alterações no âmbito do metabolismo glicídico antes dos 55 anos de idade. Este trabalho objetiva a discussão desta forma de DM, enfatizando suas características clínicas e genéticas mais relevantes. A pesquisa sistemática de mutações MODY começa a ser feita de forma rotineira em vários países, havendo uma tendência de se colocar este recurso diagnóstico como um exame na prática da diabetologia. It is estimated that close to 5% of the individuals classified as having type 2 diabetes mellitus (DM) and about 10% of those considered type 1 DM (previously categorized as juvenile type) are actual carriers of a MODY mutation. In this form of DM, there is evident co-segregation of some mutations and the advent of hyperglycemia, this fact having been reproduced by the study of several families of different populations. Its main characteristic is being one of the few causes of DM in which the transmission of the genetic susceptibility is due to an autossomical dominant inheritance, making part of the group classified as monogenic DM, where the other members are very rare. Mutations occurring in MODY genes, even in the heterozygous form, lead to a profound phenotypic impact (high penetrance), in that 95% of the individual carriers of a MODY mutation will be diabetic or will have altered glicemic metabolism before the age of 55 years. In this paper we approach this form of DM, emphasizing its most relevant clinical and genetic characteristics. The systematic search for MODY mutations is beginning to take place regularly in many countries, and there is a tendency to add this diagnostic tool to the routine exams in the practice of diabetology.
- Published
- 2002
343. Guidelines for visualization of cutaneous blood flow by laser Doppler perfusion imaging
- Author
-
Markus Stücker, K-P Wilhelm, Torkel Fischer, Christopher D. Anderson, Ann Fullerton, Gert Nilsson, Karin Wårdell, and Jørgen Serup
- Subjects
medicine.medical_specialty ,Skin Neoplasms ,integumentary system ,European community ,business.industry ,Diabetology ,Dermatology ,Blood flow ,Patch Tests ,medicine.disease ,Microcirculation ,Surgery ,Visualization ,Regional Blood Flow ,Laser-Doppler Flowmetry ,Humans ,Immunology and Allergy ,Medicine ,Radiology ,Laser doppler perfusion imaging ,business ,Perfusion ,Contact dermatitis ,Skin - Abstract
This report reviews how to set up a laser Doppler perfusion imaging system intended for visualization of skin blood perfusion, capture images and evaluate the results obtained. A brief summary of related papers published in the literature within the areas of skin irritant and allergy patch testing, microdialysis and skin tumour circulation is presented, as well as early applications within other fields such as diabetology, wound healing and microvascular research.
- Published
- 2002
344. Knowledge, Attitude and Practices of Patients Visiting a Diabetes Care Unit
- Author
-
Rubina Hakeem, Naeema Badruddin, Iqbal Hydrie, and Abdul Basit
- Subjects
medicine.medical_specialty ,Nutrition and Dietetics ,business.industry ,Public Health, Environmental and Occupational Health ,Diabetology ,Overweight ,medicine.disease ,Unit (housing) ,Family medicine ,Scale (social sciences) ,Diabetes mellitus ,medicine ,Health information ,medicine.symptom ,business ,Food Science ,Glycemic - Abstract
All patients if given proper guidance and education regarding diabetes care would be able to make significant improvement in their life-style which is helpful for good glycemic control. Education to diabetic patients would be more effective if we know the level of knowledge, attitude and practices of our patients. Thus a study was conducted to assess the general characteristics, knowledge, attitude and practices of type 2 diabetic patients attending the Out-Patient Department (OPD) of Baqai Institute of Diabetology and Endocrinology (Karachi, Pakistan). Fifty-seven percent of the patients were overweight or obese. Only 10.7% had good glycemic control. Sixty seven percent did not do exercise of any kind. The overall awareness about the risk of complications was satisfactory but the misconceptions regarding diet, insulin and diabetes were quite common. This study highlights the need for better health information to the patient through large scale awareness programmes so as to change the attitude of our public regarding diabetes.
- Published
- 2002
345. The Social Return Of Investment (SROI) applied to diabetology: the AMD project to enhance the diabetologist’s skills
- Author
-
N. Musacchio
- Subjects
Finance ,medicine.medical_specialty ,business.industry ,Return on investment ,medicine ,Diabetology ,Business - Published
- 2017
346. Glycemic management during Jain fasts
- Author
-
Sanjay Kalra, Alok Sachan, Sandeep Julka, Rajeev Chawla, Navneet Agrawal, Rakesh Sahay, Girish Parmar, Banshi Saboo, Sarita Bajaj, AG Unnikrishnan, and Manash P Baruah
- Subjects
Gerontology ,insulin ,medicine.medical_specialty ,fasting ,Endocrinology, Diabetes and Metabolism ,education ,India ,030209 endocrinology & metabolism ,Review Article ,030204 cardiovascular system & hematology ,lcsh:Diseases of the endocrine glands. Clinical endocrinology ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,Jain religion ,medicine ,lcsh:RC799-869 ,health care economics and organizations ,lcsh:RC648-665 ,business.industry ,Diabetes ,Diabetology ,humanities ,Jain ,Glycemic management ,religion ,lcsh:Diseases of the digestive system. Gastroenterology ,business - Abstract
This review describes the various fasts observed by adherents of the Jain religion. It attempts to classify them according to their suitability for people with diabetes and suggests appropriate regime and dose modification for those observing these fasts. The review is an endeavor to encourage rational and evidence-based management in this field of diabetology.
- Published
- 2017
347. Current prospects for the chemoprevention of prostate cancer
- Author
-
Thomas McNicholas, Roger Kirby, and John M. Fitzpatrick
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,Alternative medicine ,Diabetology ,Disease ,medicine.disease ,Dutasteride ,Prostate cancer ,chemistry.chemical_compound ,chemistry ,medicine ,Lifetime risk ,Intensive care medicine ,business - Abstract
Unlike other areas of medicine, such as cardiology and diabetology, urology has often been slow to embrace strategies for risk reduction. Currently, urologists prefer to treat the disease at the stage they encounter it, rather than approaching the problem with a preventative frame of mind. However, a recent publication evaluating the effect of dutasteride on prostate cancer calls this view into question. The current lifetime risk of prostate cancer in the USA is estimated at 16.7 per cent. As the disease is both extremely common and generally slow to progress, potentially it provides a prime target for chemoprevention.
- Published
- 2011
348. Prevalence of hemoglobin variants in a diabetic population at high risk of hemoglobinopathies and optimization of HbA1c monitoring by incorporating HPLC in the laboratory workup
- Author
-
Karima Khiari, Kahena Bouzid, Eya Kalai, Habib Ben Ahmed, Jaouida Abdelmoula, Nathalie Couque, A. Bahlous, and Salma Blibeche
- Subjects
Male ,Risk ,medicine.medical_specialty ,Tunisia ,HbA1c ,endocrine system diseases ,Cost-Benefit Analysis ,Short Communication ,hemoglobinopathies ,HPLC ,diabetes mellitus ,prevalence ,Population ,lcsh:Medicine ,High-performance liquid chromatography ,chemistry.chemical_compound ,Diabetes mellitus ,Internal medicine ,medicine ,Humans ,education ,Hplc method ,Chromatography, High Pressure Liquid ,Monitoring, Physiologic ,Glycated Hemoglobin ,education.field_of_study ,business.industry ,lcsh:R ,biochemistry ,endocrinology ,diabetology ,Genetic Variation ,Hemoglobin variants ,nutritional and metabolic diseases ,General Medicine ,Middle Aged ,medicine.disease ,Hemoglobinopathies ,Diabetes Mellitus, Type 1 ,Endocrinology ,Diabetes Mellitus, Type 2 ,chemistry ,Female ,Glycated hemoglobin ,business ,Algorithms ,Biomarkers - Abstract
Background : In Tunisia, diabetes mellitus and hemoglobinopathies are major public health problems. Glycated hemoglobin (HbA1c) is recommended for long-term monitoring of diabetes mellitus, but the presence of hemoglobin variants may interfere with HbA1c measurement. The aim was to determine the prevalence of hemoglobin variants in Tunisian diabetics and optimize the monitoring of diabetics using HbA1c. Methods : The study enrolled 9,792 Tunisian diabetic patients. HbA1c was measured by cation-exchange high-pressure liquid chromatography (HPLC). All the chromatograms were analyzed for the presence of Hb variants. Results : We identified 228 cases (2.33%) of Hb variants with D-10 HPLC (Bio-Rad): 191 with HbA/S trait, 27 with HbA/C trait, and 10 hemoglobin variants with the mention ‘Variant-Window’ on the chromatograms and subsequently identified as HbA/S on Variant I HPLC (Bio-Rad). Thus, the prevalence of HbS was 2.05%. We did not find any homozygous variant. All HbA1c results were reported to the treating physician. Conclusions : To evaluate glycated hemoglobin in populations with a high prevalence of hemoglobinopathies, we should use the HPLC method, which is easy, economical, and reliable. Based on an algorithm, hemoglobin variants visualized on HPLC should be reported to the physician to improve the management of patients. Keywords: hemoglobinopathies; HbA1c; HPLC; diabetes mellitus; prevalence; Tunisia (Published: 27 October 2014) Citation: Libyan J Med 2014, 9 : 25768 - http://dx.doi.org/10.3402/ljm.v9.25768
- Published
- 2014
349. Challenging Complex Diseases
- Author
-
Jonas Spaak
- Subjects
Nephrology ,medicine.medical_specialty ,business.industry ,Internal medicine ,Diabetes mellitus ,Concomitant ,Medicine ,Diabetology ,Disease ,business ,Intensive care medicine ,medicine.disease - Abstract
Patients with concomitant cardiovascular disease, renal disease and diabetes represent a large proportion of all patients in cardiology, nephrology and diabetology. A progressively increased subspecialisation has led to that the cardiologists’ treats the heart, nephrologists’ the kidneys and endocrinologists’ the diabetes. At best, this causes the patient to spend substantial time visiting multiple specialists in each field, and at worst serious under-treatment of co-morbidities. Improved ways to organize and provide health-care are needed for this large, complex group of patients
- Published
- 2014
350. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease
- Author
-
Gary K Fetter, Matthias Lannoo, Martin Gericke, Schalk Van der Merwe, David Cassiman, Petra Windmolders, Simon Nayler, An Verrijken, Jos van Pelt, Luc Van Gaal, Guy Hubens, Bart Van der Schueren, Frederik Nevens, Tom Oyen, Hannelie Korf, Chantal Mathieu, Tessa van der Merwe, Sven Francque, Baki Topal, and Johannie du Plessis
- Subjects
Nonalcoholic steatohepatitis ,Liver Cirrhosis ,Male ,Panniculitis ,Biopsy ,Bariatric Surgery ,Severity of Illness Index ,South Africa ,Belgium ,Non-alcoholic Fatty Liver Disease ,Nonalcoholic fatty liver disease ,Gene Regulatory Networks ,Metabolic disease ,Cells, Cultured ,media_common ,Oligonucleotide Array Sequence Analysis ,Gastroenterology ,Diabetology ,Middle Aged ,University hospital ,Phenotype ,Disease Progression ,Cytokines ,Female ,Inflammation Mediators ,Adult ,medicine.medical_specialty ,Subcutaneous Fat ,Intra-Abdominal Fat ,Immunophenotyping ,Predictive Value of Tests ,Internal medicine ,medicine ,media_common.cataloged_instance ,Humans ,Obesity ,European union ,Hepatology ,business.industry ,Gene Expression Profiling ,Macrophages ,nutritional and metabolic diseases ,medicine.disease ,digestive system diseases ,Family medicine ,Immunology ,Subcutaneous adipose tissue ,Human medicine ,business ,Biomarkers - Abstract
BACKGROUND & AIMS: The prevalence of nonalcoholic fatty liver disease (NAFLD) has increased with the obesity pandemic. We analyzed the transcriptional profiles of subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT), and phenotypes and functional characteristics of adipocyte tissue macrophages (ATMs), in obese patients undergoing bariatric surgery. METHODS: We collected anthropometric data; plasma samples; and SAT, VAT, and liver tissues from 113 obese patients undergoing bariatric surgery at academic hospitals in Europe (Antwerp and Leuven) and South Africa. Based on clinical and histologic features, patients were assigned to the following groups: obese, NAFLD, nonalcoholic steatohepatitis (NASH), or NASH with fibrosis. Microarray analyses were performed to identify genes expressed differentially among groups. We measured levels of cytokines and chemokines in plasma samples and levels of RNAs in adipose tissues by quantitative reverse-transcription polymerase chain reaction. ATMs were isolated from patients and 13 lean individuals undergoing cholecystectomy (controls), analyzed by flow cytometry, and cultured; immunophenotypes and levels of cytokines and chemokines in supernatants were determined. RESULTS: We observed increased expression of genes that regulate inflammation in adipose tissues from patients with NAFLD and NASH; expression of these genes increased as disease progressed from NAFLD to NASH. We found 111 genes associated with inflammation that were expressed differentially between VAT and SAT. Serum levels of interleukin 8, chemokine (C-C motif) ligand 3, and tumor necrosis factor-alpha correlated with liver inflammation and NAFLD activity score. We developed 2 models that could be used to determine patients' liver histology based on gene expression in VAT and SAT. Flow cytometry showed increased proportions of CD11c+CD206+ and CCR2+ macrophages in VAT from patients with NASH, and supernatants of cultured macrophages had increased levels of cytokines and chemokines compared with controls. CONCLUSIONS: VAT and SAT from patients with NAFLD and NASH have an increased expression of genes that regulate inflammation, and ATM produce increased levels of inflammatory cytokines, compared with adipose tissues from controls. We identified an expression profile of 5 genes in SAT that accurately predict liver histology in these patients. Transcript profiling: accession numbers: GSE58979 and GSE59045.
- Published
- 2014
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.